Brivex Trademark Details
Word Mark | Brivex |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Ligand Pharmaceuticals Incorporated of San Diego, CA
View all trademarks for Ligand Pharmaceuticals IncorporatedSerial Number | 75898916 |
---|---|
Status Date | Sunday, June 13, 2004 |
Filing Date | Sunday, June 13, 2004 |
Attorney | F.T. Alexandra Mahaney |
Correspondent
Jessica R. Wolff, Eq.
Paul, Hastings, Janofsky & Walker, LLP
P O Box 919092
San Diego CA 92191-9092
Paul, Hastings, Janofsky & Walker, LLP
P O Box 919092
San Diego CA 92191-9092
Case File Statements
Goods & Services | Pharmaceutical preparations for the use in treatment of skin related diseases, disorders of the eye, cancer and pre-cancerous conditions, cardiovascular disorders, inflammatory diseases, neuro-degenerative diseases, and disorders related to the modulation of intracellular receptor activity |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, April 26, 2000 |
Primary Code | 005 |
Trademark Timeline
-
Jan 19 2000Trademark application filed with USPTO
-
Jun 13 2000Assigned To Examiner
-
Jun 15 2000Non-Final Action Mailed
-
Aug 14 2000Correspondence Received In Law Office
-
Sep 20 2000Approved For Pub - Principal Register
-
Mar 07 2001Notice of Publication
-
Mar 20 2001Published For Opposition
-
Jun 12 2001Noa Mailed - Sou Required From Applicant
-
Dec 07 2001Extension 1 Filed
-
Dec 29 2001Extension 1 Granted
-
May 06 2002Extension 2 Filed
-
May 06 2002Paper Received
-
May 20 2002Extension 2 Granted
-
Nov 13 2002Extension 3 Filed
-
Nov 18 2002Paper Received
-
Feb 03 2003Extension 3 Granted
-
May 02 2003Paper Received
-
Jun 05 2003Paper Received
-
Jun 11 2003Extension 4 Filed
-
Jun 25 2003Teas Change of Correspondence Received
-
Jul 05 2003Extension 4 Granted
-
Dec 04 2003Extension 5 Filed
-
Dec 04 2003Paper Received
-
Jan 13 2004Extension 5 Granted
-
Jun 30 2004Case File In Ticrs
-
Aug 16 2004Abandonment - No Use Statement Filed